Search - tctmd.com

Displaying 681 - 700 of 2624

Sort: Relevancy | Date

Presentation

Revisiting Sex Equality With TAVR Outcomes

Presenter: SA. O'connor

July 16, 2015

News Daily News

MVARC文件提供了二尖瓣治疗研究的模板

Todd Neale

July 16, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

El Documento MVARC Fija el Escenario para la Investigación Terapéutica de la Válvula Mitral

Todd Neale

July 16, 2015

News Daily News

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Yael L. Maxwell

July 15, 2015

Presentation

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Presenter: Johan Bosmans

July 14, 2015

News Industry News

CryoLife Receives Expanded Indication for BioGlue® in Japan

July 09, 2015

News Industry News

FDA ruling allows heart valve patients to limit blood-thinning medication

July 08, 2015

News Industry News

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

July 07, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Daily News

活动能力差可强烈预测 TAVR 患者死亡率

Yael L. Maxwell

July 06, 2015

News Daily News

Una Peor Movilidad es Fuertemente Predictiva de la Mortalidad en Pacientes TAVR

Yael L. Maxwell

July 06, 2015

News Daily News

Poor Mobility Strongly Predicts Mortality in TAVR Patients

Yael L. Maxwell

July 06, 2015

Presentation

2-Year Outcomes in Patients Undergoing Surgery or Self-Expanding TAVR

Presenter: Michael J. Reardon

July 06, 2015

News Daily News

Un Comunicado sobre el Cierre del AAI Señala los Puntos clave en este Campo

July 02, 2015

News Daily News

Statement on LAA Closure Highlights Key Issues for Growing Field

July 02, 2015

Advertisement

Revisiting Sex Equality With TAVR Outcomes

MVARC文件提供了二尖瓣治疗研究的模板

MVARC Document Offers Template for Mitral Valve Therapeutics Research

El Documento MVARC Fija el Escenario para la Investigación Terapéutica de la Válvula Mitral

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

CryoLife Receives Expanded Indication for BioGlue® in Japan

FDA ruling allows heart valve patients to limit blood-thinning medication

Thoratec Announces First HeartMate 3™ Implant in European Less Invasive Surgical Trial

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

活动能力差可强烈预测 TAVR 患者死亡率

Una Peor Movilidad es Fuertemente Predictiva de la Mortalidad en Pacientes TAVR

Poor Mobility Strongly Predicts Mortality in TAVR Patients

2-Year Outcomes in Patients Undergoing Surgery or Self-Expanding TAVR

Un Comunicado sobre el Cierre del AAI Señala los Puntos clave en este Campo

Statement on LAA Closure Highlights Key Issues for Growing Field

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content